Prophylactic and early targeted treatment of patent ductus arteriosus

Seminars in Fetal and Neonatal Medicine

Volumn 23, Issue 4, 2018, Pages 250-254

  Wyllie, Jonathan P ^a,b   Gupta, Samir ^b,c  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b DURHAM UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

Author keywords

Early targeted treatment; Ibuprofen; Indomethacin; Patent ductus arteriosus; Preterm; Prophylactic treatment

Indexed keywords

ETAMSYLATE; IBUPROFEN; INDOMETACIN;

DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART PROTECTION; HEART SURGERY; HUMAN; LOADING DRUG DOSE; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; PREMATURITY; PULSATILE FLOW; REVIEW; NEWBORN;

DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE;

EID: 85044116284     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2018.03.005     Document Type: Review

References (48)

1. Teitel, D.F., Iwamote, H.S., Rudolph, A.M., Changes in the pulmonary circulation during birth-related events. Pediatr Res, 27, 1990, 372.
2. Born, G.V.R., Dawes, G.S., Mott, J.C., Widdicombe, J.G., Changes in the heart and lungs at birth. Cold Spring Harbor Symp Quant Biol 19 (1954), 102–108.
3. Black, S.M., Johengen, M.J., Ma, Z.D., Bristow, J., Soifer, S.J., Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs. J Clin Invest, 100, 1997, 1448.
4. Heymann, M.A., Control of the pulmonary circulation in the fetus and during the transitional period to air breathing. Eur J Obstet Gynecol Reprod Biol, 84, 1999, 127.
5. Skinner, J.R., Boyes Hunter, S., Hey, E.N., Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch Dis Child, 67, 1992, 366.
6. Clarke, W.R., The transitional circulation: physiology and anaesthetic implications. J Clin Anesth 2 (1990), 192–211.
7. Walsh-Sukys, M., Persistent pulmonary hypertension of the newborn. Clin Perinatol, 20, 1993, 127.
8. Gittenberger-de Groot, A.C., Van Ertbruggen, I., Moulaert, A.J.M.G., Harinck, E., The ductus arteriosus in the preterm infant: histologic and clinical observations. J Pediatr 96 (1980), 88–93.
9. Hiraishi, S., Misawa, H., Oguchi, K., Two-dimensional Doppler echocardiographic assessment of closure of the ductus arteriosus in normal newborn infants. J Pediatr 111 (1987), 755–760.
10. Daniels, O., Hopman, J.C.W., Stoelinga, G.B.A., Busch, H.J., Peer, P.G.M., Doppler flow characteristics in the main pulmonary artery and the LA/AO ratio before and after ductal closure in healthy newborns. Pediatr Cardiol 3 (1982), 99–104.
11. Gentile, R., Stevenson, G., Dooley, T., Franklin, D., Kawabori, I., Pearlman, A., Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr 98 (1981), 443–448.
12. Ellison, R.C., Peckham, G.J., Lang, P., et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 71 (1983), 364–372.
13. Milne, M.J., Sung, R.Y.T., Fok, T.F., Crozier, I.G., Doppler echocardiographic assessment of shunting via the ductus arteriosus in newborn infants. Am J Cardiol 64 (1989), 102–105.
14. Reller, M.D., Zeigler, M.L., Rice, M.J., Solin, R.C., McDonald, R.W., Duration of ductal shunt in healthy preterm infants: an echocardiographic color flow Doppler study. J Pediatr 112 (1989), 441–446.
15. Moss, A.J., Emmanoulides, G.C., Adams, F.H., Chuang, K., Response of the ductus arteriosus and pulmonary and systemic arterial pressure to changes in oxygen environment in newborn infants. Pediatrics 33 (1964), 937–944.
16. Clyman, R.I., Mauray, F., Wong, L., Heymann, M.A., Rudolph, A.M., The developmental response of the ductus arteriosus to oxygen. Biol Neonate 34 (1978), 177–181.
17. Clyman, R.I., Mauray, F., Rudolph, A.M., Heymann, M.A., Age dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins. J Pediatr 96 (1980), 94–98.
18. Olley, P.M., Coceani, F., Lipid mediators in the control of the ductus arteriosus. Am Rev Respir Dis 136 (1987), 218–219.
19. Clyman, R.I., Ductus arteriosus: current theories of prenatal and postnatal regulation. Semin Perinatol 4 (1980), 115–124.
20. Coceani, F., Olley, P.M., The control of cardiovascular shunts in the fetal and neonatal period. Can J Physiol Pharmacol 66 (1988), 1129–1134.
21. Clyman, R.I., Campbell, D., Heymann, M.A., Mauray, F., Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of the patent ductus arteriosus after indomethacin-induced closure. Circulation 71 (1985), 141–145.
22. Clyman, R.I., Saugstad, O.D., Mauray, F., Oxygen metabolites stimulate prostaglandin E-2 production and relaxation of the ductus arteriosus. Clin Res, 36, 1988, 228A.
23. Evans, N., Moorcraft, J., Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child 67 (1992), 1169–1173.
24. Sellmer, A., Bjerre, J.V., Schmidt, M.R., et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed 98 (2013), F505–F510.
25. Noori, S., McCoy, M., Friedlich, P., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123 (2009), e138–e144.
26. Vanhaesebrouck, S., Zonnenberg, I., Vandervoort, P., Brunnel, E., Van Hoestenberghe, M.-R., Theysens, C., Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed, 4, 2007 F244–7.
27. Sung, S.I., Chang, Y.S., Chun, J.Y., et al. J Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr 177 (2016), 66–71.
28. Clyman, R.I., Ballard, P.L., Sniderman, S., et al. Prenatal administration of betamethasone for prevention of ductus arteriosus. J Pediatr 98 (1981), 123–126.
29. Waffern, F., Siassi, B., Cabal, L.A., Schmidt, P.L., Effect of antenatal glucocorticoids on clinical closure of the ductus arteriosus. Am J Dis Child 137 (1983), 336–338.
30. Morales, W.J., Angel, J.L., O'Brien, W.F., Knuppel, R.A., Use of ampicillin and corticosteroids in premature rupture of membranes: a randomised controlled study. Obstet Gynecol 73 (1989), 721–726.
31. Papanicolaou, N., Safar, M., Hornych, A., et al. The release of renal prostaglandins during saline infusion in normal and hypertensive subjects. Clin Sci Mol Med 49 (1975), 459–463.
32. De Buyst, J., Rakza, T., Pennaforte, T., Johansson, A.B., Storme, L., Hemodynamic effects of fluid restriction in preterm infants with significant patent ductus arteriosus. J Pediatr 161 (2012), 404–408.
33. Bell, E.F., Warburton, D., Stonestreet, B.S., Oh, W., Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 302 (1980), 598–604.
34. Clyman, R.I., Rudolph, A.M., Patent ductus arteriosus: a new light on an old problem. Pediatr Res 12 (1978), 92–94.
35. Rosenfeld, W., Sadhev, S., Burnot, V., Jhaveri, R., Zabaleta, I., Evans, H.E., Phototherapy effect on the incidence of patent ductus arteriosus in premature infants: prevention with chest shielding. Pediatrics 78 (1986), 10–14.
36. Benson, J.W.T., Hayward, C., Osborne, J.P., et al. Multicentre trial of ethamsylate for prevention of periventricular hemorrhage in very low birth weight infants. Lancet 2 (1986), 1297–1300.
37. Cassady, G., Grouse, D.T., Kirklin, J.W., et al. A randomized trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000g or less at birth. N Engl J Med 320 (1989), 1511–1516.
38. Fowlie, P.W., Davis, P.G., Cochrane Review: prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Evid Base Child Health 5 (2010), 416–471.
39. Ohlsson, A., Walia, R., Shah, S.S., Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev, 2, 2015 CD003481.
40. Ohlsson, A., Shah, S.S., Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev, 7, 2011 CD004213.
41. Zaffanello, M., Brugnara, M., Bruno, C., et al. Renal function and volume of infants born with a very low birth-weight: a preliminary cross-sectional study. Acta Paediatr 99 (2010), 1192–1198.
42. Harkin, P., Harma, A., Aiko, O., et al. Paracetamol accelerates closure of the ductus arteriosus after premature birth: a randomized trial. J Peds 177 (2016), 72–77.
43. Zarkesh, M.R., Nili, F., Akbari Asbagh, P., Nayeri, F.S., Tofighi Naeem, A., Prophylactic treatment with oral paracetamol for patent ductus arteriosus in preterm infants admitted in NICU Vali-Asr Hospital in 2012. Iran J Pediatr (Persian Ed), 23, 2013, S54.
44. Mallya, P., Gupta, S., To treat or not to treat a patent ductus arteriosus (PDA): is this question valid for extreme premature babies?. EP P, 4528, 2012, 463.
45. Nemerofsky, S., Parravicini, E., Kleinman, C., et al. The natural course of the ductus arteriosus in very low birthweight infants. EP P, 59, 2006, 542.
46. El-Khuffash, A., James, A.T., Corcoran, J.D., et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 167 (2015), 1354–1361 e2.
47. Cooke, L., Steer, P.A., Woodgate, P.G., Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev, 1, 2003 CD003745.
48. Kluckow, M., Jeffrey, M., Gill, A., Evans, N., A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99 (2014), F99–F104.